Skip Navigation

Cardiovascular Research 2003 59(1):234-240; doi:10.1016/S0008-6363(03)00343-2
© 2003 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Elhage, R.
Right arrow Articles by Hansson, G. K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Elhage, R.
Right arrow Articles by Hansson, G. K
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2003, European Society of Cardiology

Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice

Rima Elhagea,b, Jacek Jawiena, Mats Rudlingc, Hans-Gustaf Ljunggrend, Kiyoshi Takedae, Shizuo Akirae, Francis Bayardb and Göran K Hanssona,*

aDepartment of Medicine at Karolinska Hospital and Center for Molecular Medicine L8:03, Karolinska Institute, SE-17176 Stockholm, Sweden
bINSERM U397, Institut Louis Bugnard, Toulouse, France
cCenter for Metabolism and Endocrinology, Department of Medicine, and Center for Nutrition and Toxicology, Novum, Karolinska Institute at Huddinge University Hospital, Stockholm, Sweden
dCenter for Infectious Medicine, Department of Medicine, Karolinska Institute at Huddinge University Hospital, Stockholm, Sweden
eDepartment of Host Defense, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan

goran.hansson{at}cmm.ki.se

* Corresponding author. Tel.: +46-8-5177-3227; fax: +46-8-313-147.

Objective: Atherosclerosis is an inflammatory disease in which T helper 1 (Th1) immunity has been proposed to play an important role. Naïve CD4+ T cells differentiate into interferon-{gamma} (IFN-{gamma}) producing Th1 effector cells when stimulated by interleukin-18 (IL-18) and IL-12. We wanted to directly test whether the Th1 pathway is proatherogenic. Methods: We bred IL-18–/– mice with apolipoprotein E–/– (apoE–/–) mice and assessed atherosclerosis in the aortic root of the offspring. Results: 24-week-old IL-18 deficient apoE–/– mice exhibited substantially reduced lesion size (93 866±11 273 vs. 144 019±9667 µm2 in IL-18+/+xapoE–/– mice, P = 0.005). Lesion cells in compound knockout mice displayed reduced I-Ab expression, implying reduced local IFN-{gamma} stimulation. These mice also had an increased proportion of {alpha}-SM-actin+ smooth muscle cells, compatible with a more stable lesion phenotype. Immunoglobulin G (IgG) subclass analysis of antibodies to malondialdehyde-modified low density lipoprotein indicated increased Th2 and reduced Th1 helper to B cell antibody production. Surprisingly, serum cholesterol and triglyceride levels were significantly higher in IL-18–/–xapoE–/– mice in spite of their reduced atherosclerosis. However, no changes in lipoprotein cholesterol patterns were registered. Conclusion: These data show reduced atherosclerosis and Th1 activity in spite of increased serum cholesterol in IL-18 deficient apoE–/– mice. They support a proatherogenic role for IL-18.

KEYWORDS Atherosclerosis; Interleukin-18; T cells; Inflammation; Mouse models


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
Z. Mallat, S. Taleb, H. Ait-Oufella, and A. Tedgui
The role of adaptive T cell immunity in atherosclerosis
J. Lipid Res., April 1, 2009; 50(Supplement): S364 - S369.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
F. Montecucco and F. Mach
Common inflammatory mediators orchestrate pathophysiological processes in rheumatoid arthritis and atherosclerosis
Rheumatology, January 1, 2009; 48(1): 11 - 22.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Kleemann, S. Zadelaar, and T. Kooistra
Cytokines and atherosclerosis: a comprehensive review of studies in mice
Cardiovasc Res, August 1, 2008; 79(3): 360 - 376.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Mayr, A. Zampetaki, A. Sidibe, U. Mayr, X. Yin, A. I. De Souza, Y.-L. Chung, B. Madhu, P. H. Quax, Y. Hu, et al.
Proteomic and Metabolomic Analysis of Smooth Muscle Cells Derived From the Arterial Media and Adventitial Progenitors of Apolipoprotein E-Deficient Mice
Circ. Res., May 9, 2008; 102(9): 1046 - 1056.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. C. Doran, N. Meller, and C. A. McNamara
Role of Smooth Muscle Cells in the Initiation and Early Progression of Atherosclerosis
Arterioscler. Thromb. Vasc. Biol., May 1, 2008; 28(5): 812 - 819.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
K. Y Stokes and D. N. Granger
The microcirculation: a motor for the systemic inflammatory response and large vessel disease induced by hypercholesterolaemia?
J. Physiol., February 1, 2005; 562(3): 647 - 653.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.